
Genetic Technologies Limited GENE
Annual report 2022
added 08-30-2022
Genetic Technologies Limited DIO Ratio 2011-2026 | GENE
Annual DIO Ratio Genetic Technologies Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 42.1 | 71.8 | 56.9 | 82 | 130 | 42.3 | 40.1 | 59.3 | - |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 130 | 40.1 | 65.6 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | ||
|
Burning Rock Biotech Limited
BNR
|
243 | $ 34.5 | 2.16 % | $ 371 M | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
BioNano Genomics
BNGO
|
245 | $ 1.29 | -12.26 % | $ 1.64 M | ||
|
Castle Biosciences
CSTL
|
48.7 | $ 39.74 | 1.48 % | $ 1.1 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
304 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
92.9 | $ 219.29 | -0.08 % | $ 160 B | ||
|
Exact Sciences Corporation
EXAS
|
240 | $ 102.41 | 0.1 % | $ 19 B | ||
|
Fulgent Genetics
FLGT
|
7.17 | $ 26.19 | -0.19 % | $ 792 M | ||
|
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | ||
|
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | ||
|
Guardant Health
GH
|
78.4 | $ 113.17 | 2.43 % | $ 13.9 B | ||
|
DexCom
DXCM
|
119 | $ 73.31 | -0.93 % | $ 28.3 B | ||
|
CareDx, Inc
CDNA
|
48.3 | $ 20.55 | -1.23 % | $ 1.1 B | ||
|
DarioHealth Corp.
DRIO
|
165 | $ 10.2 | -0.97 % | $ 289 M | ||
|
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
44.2 | $ 66.91 | 0.34 % | $ 4.63 B | ||
|
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
137 | $ 144.81 | -3.26 % | $ 23 B | ||
|
NeoGenomics
NEO
|
25.1 | $ 11.99 | -3.35 % | $ 1.52 B | ||
|
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B | ||
|
Charles River Laboratories International
CRL
|
35.3 | $ 210.51 | -0.59 % | $ 10.8 B | ||
|
Personalis
PSNL
|
12.1 | $ 9.33 | -6.42 % | $ 553 M | ||
|
Quest Diagnostics Incorporated
DGX
|
10.4 | $ 186.45 | 2.27 % | $ 20.7 B | ||
|
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
21.7 | $ 24.07 | -0.78 % | $ 31.2 M | ||
|
Laboratory Corporation of America Holdings
LH
|
18.8 | $ 271.34 | 0.56 % | $ 22.8 B | ||
|
Mettler-Toledo International
MTD
|
79 | $ 1 370.47 | -1.61 % | $ 29.1 B | ||
|
ICON Public Limited Company
ICLR
|
0.213 | $ 181.44 | -2.39 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
91.6 | $ 672.84 | -0.57 % | $ 55.5 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 28.66 | -2.02 % | $ 20 B | ||
|
Agilent Technologies
A
|
97.1 | $ 133.33 | 0.07 % | $ 40.5 B | ||
|
Biomerica
BMRA
|
147 | $ 2.41 | 0.84 % | $ 5.54 M |